Malar J by Wanja, Elizabeth et al.
Wanja et al. Malar J  (2017) 16:221 
DOI 10.1186/s12936-017-1856-2
RESEARCH
Evaluation of a laboratory quality 
assurance pilot programme for malaria 
diagnostics in low-transmission areas of Kenya, 
2013
Elizabeth Wanja1, Rachel Achilla1,2, Peter Obare1,2^, Rose Adeny1,2, Caroline Moseti1,2, Victor Otieno1,2, 
Collins Morang’a1,2, Ephantus Murigi3, John Nyamuni3, Derek R. Monthei1, Bernhards Ogutu1,2 
and Ann M. Buff4,5*
Abstract 
Background: One objective of the Kenya National Malaria Strategy 2009–2017 is scaling access to prompt diagno-
sis and effective treatment. In 2013, a quality assurance (QA) pilot was implemented to improve accuracy of malaria 
diagnostics at selected health facilities in low-transmission counties of Kenya. Trends in malaria diagnostic and QA 
indicator performance during the pilot are described.
Methods: From June to December 2013, 28 QA officers provided on-the-job training and mentoring for malaria 
microscopy, malaria rapid diagnostic tests and laboratory QA/quality control (QC) practices over four 1-day visits at 
83 health facilities. QA officers observed and recorded laboratory conditions and practices and cross-checked blood 
slides for malaria parasite presence, and a portion of cross-checked slides were confirmed by reference laboratories.
Results: Eighty (96%) facilities completed the pilot. Among 315 personnel at pilot initiation, 13% (n = 40) reported 
malaria diagnostics training within the previous 12 months. Slide positivity ranged from 3 to 7%. Compared to the 
reference laboratory, microscopy sensitivity ranged from 53 to 96% and positive predictive value from 39 to 53% for 
facility staff and from 60 to 96% and 52 to 80%, respectively, for QA officers. Compared to reference, specificity ranged 
from 88 to 98% and negative predictive value from 98 to 99% for health-facility personnel and from 93 to 99% and 
99%, respectively, for QA officers. The kappa value ranged from 0.48–0.66 for facility staff and 0.57–0.84 for QA officers 
compared to reference. The only significant test performance improvement observed for facility staff was for speci-
ficity from 88% (95% CI 85–90%) to 98% (95% CI 97–99%). QA/QC practices, including use of positive-control slides, 
internal and external slide cross-checking and recording of QA/QC activities, all increased significantly across the pilot 
(p < 0.001). Reference material availability also increased significantly; availability of six microscopy job aids and seven 
microscopy standard operating procedures increased by a mean of 32 percentage points (p < 0.001) and 38 percent-
age points (p < 0.001), respectively.
Conclusions: Significant gains were observed in malaria QA/QC practices over the pilot. However, these advances 
did not translate into improved accuracy of malaria diagnostic performance perhaps because of the limited duration 
of the QA pilot implementation.
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Background
In Kenya, malaria accounts for more than 20% of outpa-
tient visits, 19% of hospital admissions, and 3–5% of hos-
pital deaths and is a leading cause of mortality in children 
less than 5 years of age [1, 2]. Approximately 70% of the 
population in Kenya lives in areas at risk of malaria trans-
mission [3]. Prompt and accurate diagnosis of malaria is 
an important component of malaria case management. 
In 2010, the World Health Organization (WHO) rec-
ommended that all patients with suspected uncompli-
cated malaria should receive a parasitological test prior 
to treatment [4]. Correct diagnosis of malaria reduces 
unnecessary treatment with expensive artemisinin-based 
combination therapy (ACT), helps prevent the develop-
ment of drug resistance and increases the likelihood of 
correct treatment for other febrile illnesses [4, 5].
Both the WHO policy on malaria diagnostics and the 
Kenya National Malaria Strategy 2009–2017 recommend 
the use of microscopy and quality-controlled malaria 
rapid diagnostic tests (RDT) for parasitological diagno-
sis of malaria [3, 4]. Microscopy has been the primary 
method for malaria diagnosis historically and was avail-
able in 56% of health facilities in Kenya in early 2013 [6]. 
Microscopy requires well-trained microscopists as well 
as functional equipment, supplies and electricity [5]. 
Training of staff in centres of excellence can improve 
the capacity of individual microscopists; however, when 
trained microscopists return to health-facility laborato-
ries, they often face many challenges such as poor-quality 
reagents, non-functional equipment, heavy workloads 
and lack of trust in results by clinicians [5, 7]. These chal-
lenges can contribute to the marginal improvements 
in the performance observed after training. The lack of 
institutional laboratory quality assurance programmes 
and structured periodic supportive supervision to iden-
tify problems and take corrective actions also contribute 
to the slow progress toward improving access to quality 
malaria diagnostics [5, 8].
Malaria RDTs are recommended by WHO due to 
affordability, availability and accuracy [9, 10]. In early 
2013, only 31% of health facilities in Kenya had malaria 
RDTs, but 76% of health facilities had either functional 
microscopy or RDTs available [6]. One objective of the 
Kenya National Malaria Strategy 2009–2017 is scaling 
and sustaining access to prompt diagnosis and effective 
treatment to the entire population [3]. Part of the imple-
mentation of the national strategy has been to strengthen 
laboratory diagnosis of malaria across all levels of the 
health care system and in all epidemiological zones. 
Beginning in June 2013, the National Malaria Control 
Programme (NMCP), Ministry of Health (MOH), imple-
mented a pilot malaria diagnostics quality assurance 
(QA) programme. The QA programme was implemented 
first in health facilities in low-transmission areas because 
routine health data showed that over-diagnosis of malaria 
was common despite a low prevalence of parasitaemia 
[11, 12]. The trends in improvements and challenges after 
the pilot phase of the QA programme implementation in 
low-transmission areas from June to December 2013 are 
reported.
Methods
Study sites
Eighty-three health facilities were purposefully selected 
for the pilot QA programme which was implemented 
from June to December 2013 in the low-transmission 
counties, defined as having an estimated population-
adjusted parasitaemia prevalence of <5%, of the Rift 
Valley (n =  36), Central (n =  33) and Eastern (n =  14) 
regions of Kenya [1, 13]. The health facilities were 
widely distributed in 23 (49%) of 47 counties and repre-
sented approximately 2% of health facilities in the three 
low-transmission regions. To be included in the QA 
programme, the health facility had to provide malaria 
microscopy services.
Training
Twenty-eight laboratory personnel were selected by 
the regional medical laboratory coordinators based on 
malaria microscopy competence, communication skills 
and potential to teach and mentor others. These individu-
als were primarily assigned to primary or secondary pub-
lic hospital laboratories, held supervisory positions, and 
attended malaria microscopy refresher training within 
the last year. To become QA officers, selected laboratory 
personnel attended a 2-week QA training which con-
sisted of 5 days of malaria diagnostics training and 5 days 
of formal quality assurance/quality control (QA/QC) 
methods and laboratory management systems training in 
accordance with ISO standard 15189. Training was con-
ducted at the Malaria Diagnostics Center (MDC), Kenya 
Medical Research Institute (KEMRI) and U.S. Army 
Medical Research Directorate-Kenya, Kisumu, Kenya. 
The QA officers underwent bi-annual proficiency test-
ing to ensure they maintained the requisite proficiency 
to cross-check slides and serve as mentors to laboratory 
personnel in supported health facilities. None of the QA 
officers required remedial training for poor performance 
during the implementation period evaluated.
Key components of QA programme
The MDC provided formal training to the QA officers 
and NMCP staff in QA/QC methods. The QA officers 
implemented informal training, mentoring and support-
ive supervision for health-facility laboratory person-
nel and simple quality management systems using a 
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standardized checklist in health-facility laboratories 
to improve malaria diagnosis by both microscopy and 
RDTs. Table 1 describes the eight key components of the 
QA programme. The standardized malaria diagnostics 
QA checklist used by QA officers is Additional file 1.
QA programme implementation and data collection
Health facilities for the initial pilot were identified by 
QA officers, in consultation with supervisory laboratory 
staff, based on the distance from each QA officer’s pri-
mary duty location. The QA officers did not administer 
the pilot QA programme in the facilities to which they 
were permanently assigned. The three health facilities 
that were generally closest to the QA officer’s primary 
duty station and that had malaria diagnostic services 
were purposefully chosen for QA programme support. 
Twenty-seven QA officers were assigned three health 
facilities each for support, and one was assigned two 
facilities because of distances in a remote area. There-
fore, the facilities formed a convenience sample based 
on travel time for the QA officers. Over the 7-month 
pilot period in 2013, QA officers made 1-day visits in the 
months of June, July, November and December to each 
health facility for a total of four visits per facility.
At the initiation of the programme, each QA officer 
was given seed commodities (i.e., slides, slide mailers, 
slide boxes, Giemsa and immersion oil) to distribute to 
the health facilities during their first QA visit. Each QA 
officer was expected to cross-check five negative and 
five weak-positive slides (i.e., ten total slides) for accu-
racy at each facility during every visit in accordance with 
national and WHO guidance [5, 14]. Thick films were 
examined for the presence or absence of parasites; a min-
imum of 100 high-power magnification fields were exam-
ined before the slide was classified as negative [5, 14]. No 
thin films were collected or examined for parasite density 
or speciation as part of the QA pilot programme, and no 
slides were collected during the first visit. Because the 
QA programme was implemented in low-transmission 
counties, five weak-positive slides were not always availa-
ble to cross-check; in such cases, the QA officer collected 
additional negative slides to ensure 10 slides in total were 
checked.
Each QA officer completed a standardized check-
list with 17 discrete sections that covered the eight QA 
components during each visit (Additional file  1). The 
QA officers recorded data on specific indicators and 
processes via observation and structured questions. The 
data was used in real time to tailor the interventions the 
QA officer provided during the visit and was analysed to 
evaluate the QA pilot. Sections 1–4 covered basic health 
facility information including staffing, training and infra-
structure. Sections  5–7 covered the availability of labo-
ratory equipment, supplies and consumables including 
RDTs. QA officers observed and visually confirmed the 
presence or absence and count of laboratory equipment, 
which they recorded on the checklist. QA officers also 
visually confirmed the presence of supplies and con-
sumables and asked the supervisory laboratory officer if 
the laboratory had experienced a stock out of 7 or more 
consecutive days during the previous 3 months that pre-
vented the laboratory from performing malaria diagnos-
tics. In addition, dates were recorded when available (e.g., 
last maintenance date for microscopes).
Section  8 of the checklist covered malaria reference 
materials, which were visually verified as being present or 
absent and the location of the material was documented. 
Reference materials included the national malaria policy 
and guidelines for laboratory, diagnosis and treatment, 
and quality assurance. Reference materials also veri-
fied were jobs aids and standard operating procedures 
(SOPs). QA officers documented the availability of one 
SOP for RDT use and nine SOPs related to microscopy: 
(1) collection of blood samples, (2) preparation of blood 
films, (3) preparation of buffered water, (4) preparation 
of Giemsa, (5) preparation of Field stain, (6) staining of 
blood films, (7) examination of blood films, (8) slide 
selection for QA/QC, and (9) use, care and maintenance 
of microscopes. The SOPs for microscopy are described 
in detail in the national guidelines for parasitological 
diagnosis of malaria [14]. QA officers documented the 
availability of one job aid for RDT use and six related to 
microscopy: (1) malaria microscopy images, (2) sample 
collection, (3) smear preparation, (4) staining, (5) smear 
Table 1 Key components of  the laboratory quality assur-
ance programme
RDT rapid diagnostic test, QA/QC quality assurance/quality control, SOP standard 
operating procedure
Component Example
Personnel training and competen-
cies
Microscopy/malaria RDT trainings, 
proficiency testing
Essential laboratory equipment 
and utilities
Functional microscopes, electricity, 
water
Essential laboratory consumables 
and supplies
Slides, stain, gloves
Reference materials National laboratory guidelines, 
bench and job aides
Internal QA/QC practices SOP for equipment calibration, slide 
cross-checking
External QA/QC programmes Stepwise Laboratory Improvement 
Process Towards Accreditation 
(SLIPTA)
Standard operating procedures Specimen collection, slide prepara-
tion
Safety practices Personal protective equipment use, 
waste disposal
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examination and reporting, and (6) slide selection and 
validation. QA officers additionally documented whether 
the job aids and SOPs had been updated in the previous 
12 months.
Sections  9 and 10 covered internal and external QA 
practices. Six internal QA processes were evaluated as 
present or absent by either observation or asking the 
supervisory laboratory officer structured questions. The 
six processes were (1) batch testing of stain using posi-
tive-control slides, (2) pH meter calibration, (3) slide 
cross-checking, (4) QA process and results recording, 
(5) slide filing, and (6) slide storage. For external QA, QA 
officers asked the supervisory laboratory officer three 
yes-or-no questions related to external QA programme 
participation, which were (1) participation in a malaria-
specific external QA programme, (2) participation in any 
external QA programmes [e.g., WHO Stepwise Labo-
ratory Improvement Process Towards Accreditation 
(SLIPTA) programme], and (3) feedback received from 
external QA programme. The name or affiliation of the 
programme conducting the external QA and last valida-
tion dates were documented where available. Section 11 
covered the laboratory turnaround time for both slide 
and RDT results; the results are not reported.
Sections  12–14 were observations of laboratory staff 
preparing patients and slides, staining and reading slides 
and using RDTs. For slide preparation, there were nine 
discrete procedures observed and each procedure had 
between one and seven steps. For slide staining and read-
ing, there were six discrete procedures observed and each 
had between one and five steps. For RDT use, there were 
six discrete procedures observed and each had between 
two and six steps.
The procedures and steps are described in the stand-
ardized malaria diagnostics QA checklist (Additional 
file  1). The QA officers observed the procedures and 
recorded the number of steps completed correctly by 
laboratory staff for each. However, the results are not 
reported because the same laboratory staff were not 
observed serially over the course of the QA pilot.
Section  15 documented six laboratory safety issues 
including the presence or absence of two laboratory 
safety SOPs: infection prevention (i.e., use of personal 
protective equipment [PPE]) and post-exposure prophy-
laxis. The QA officers also observed the presence or 
absence of the following safety practices in the labora-
tory: (1) availability of material safety data sheets, (2) 
use of PPE, (3) segregation and disposal of waste, and 
(4) container labelling. Sections 16 and 17 of the check-
list were a summary of findings identified during the QA 
visit, recommendations and signatures.
Inaccuracies or deficiencies identified by the QA 
officer were immediately addressed through on-the-job 
training and mentoring of health-facility personnel dur-
ing the visit. The findings and recommendations were 
also shared with the health-facility laboratory manager 
and head administrator at the completion of each visit. 
Laboratory managers and administrators were responsi-
ble for implementing corrective actions recommended by 
the QA officer. Completed checklists and cross-checked 
slides were sent to MDC with a written report that 
included a summary of findings and recommendations 
after each visit.
All ten slides cross-checked on the second, third and 
fourth visits were sent for review by expert microscopists. 
Because of the large number of slides generated, slides 
were distributed to three reference laboratories: MDC, 
National Malaria Reference Laboratory and Kisumu 
County Vector Borne Disease Laboratory. Reference lab-
oratory microscopists were certified through the WHO 
External Competency Assessment for Malaria Micros-
copy scheme. The NMCP and MDC staff conducted one 
supportive supervision visit with QA officers to 30% of 
health facilities during the pilot phase.
Data analysis
Data from all completed checklists was analysed using 
Stata 12 (StataCorp, College Station, TX, USA). Data 
collected from the first QA officer visit to each facil-
ity in June 2013 was used as the baseline. The final data 
was collected during the last QA visit in December 2013. 
Two-by-two tables were developed for the dichotomous 
variables at baseline and after the intervention. McNe-
mar’s test, a non-parametric test for paired nominal data, 
was used to determine if the proportions were different 
before and after the QA pilot programme implementa-
tion [15]. P values were calculated for interpretation of 
statistical significance.
Slide reader data was entered and analysed in Excel 
2010 (Microsoft, Seattle, WA, USA) and Graphpad Prism 
V5.01 (Graphpad Software, CA, USA). The specificity, 
sensitivity, positive predictive value (PPV), negative pre-
dictive value (NPV) and 95% confidence intervals (CI) 
were calculated; slides read by health-facility laboratory 
personnel were compared to the reference laboratory 
and slides read by the QA officers were compared to the 
reference laboratory. The Kappa statistic (κ) and 95% CIs 
were also calculated for inter-reader agreement between 
health-facility laboratory personnel and QA officers com-
pared to the reference laboratory for each visit [16].
Ethics, consent and permission
This external QA pilot evaluation was conducted from 
routine monitoring and evaluation data collected as 
part of the NMCP’s programmatic implementation. 
Health-facility administrators and laboratory supervisors 
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attended an orientation workshop to familiarize them 
with the QA programme prior to the start of the pilot. 
Administrators and laboratory supervisors agreed to 
participate in the QA programme and provided writ-
ten acknowledgement of findings and recommendations 
at each QA visit via the standardized malaria diagnos-
tics QA checklist (Additional file  1). No compensation 
or incentives were provided to the participating health 
facilities or any health-facility personnel except the seed 
stocks of laboratory supplies that were distributed to all 
participating health facilities as part of the programme. 
No personal identifying information was collected from 
patients or laboratory personnel.
Results
Of the 83 health facilities selected for the pilot phase of 
the QA programme, 63 (76%) were public, 2 (2%) were 
private for profit, and 18 (22%) were faith-based. Twenty-
three (28%) were dispensaries, 32 (39%) were health cen-
tres, 26 (31%) were primary hospitals and two (2%) were 
referral hospitals. Although the QA programme began 
with 83 health facilities, by the fourth visit three health 
facilities had stopped participating. Only data from the 
80 health facilities that completed the full pilot period 
were included in subsequent analysis.
All 80 participating facilities had the capacity to con-
duct microscopy services. However, not all facilities pro-
vided microscopy services during every QA visit due to 
limitations such as power outages, absent laboratory staff 
or lack of supplies. During the first QA visit, 52 (65%) 
performed only malaria microscopy, 6 (8%) offered only 
malaria RDTs and 22 (28%) performed both microscopy 
and RDTs. A total of 315 full-time laboratory staff were 
reported during the first QA visit across 80 facilities; 247 
(78%) were laboratory technologists with a minimum 
of 3  years of formal training (i.e., diploma level) and 68 
(22%) were technicians with a minimum of 2  years of 
formal training (i.e., certificate level). Among the 315 
laboratory personnel, 40 (13%) reported malaria diagnos-
tics-related refresher training in the previous 12 months. 
Nineteen (6%) reported malaria microscopy refresher 
training, and 21 (7%) reported malaria RDT training.
Among the 80 health facilities, the total number of 
microscopes for all facilities was 194; only 64% (n = 125) 
of microscopes were functional with an average of 1.8 
(range 1–5) functional microscopes per facility. Func-
tional microscopes were defined as having all essential 
parts and working properly as determined by the QA 
officers. During the first visit, 70% (n  =  56) of facili-
ties documented performing daily equipment mainte-
nance, and by the fourth visit, 85% (n = 68) of facilities 
documented performing daily equipment maintenance 
(p = 0.02). Although the majority of health facilities had 
basic laboratory equipment, less than a third of facili-
ties were observed to have laboratory items such as tally 
counters and calculators as shown in Fig. 1. The percent-
age of facilities with staining racks (75–96%, p < 0.001), 
slide drying racks (78–93%, p  =  0.02) and slide boxes 
(45–96%, p < 0.001) increased between the first and last 
QA visits.
Fig. 1 Health facilities with laboratory equipment in malaria low-transmission areas of Kenya, June–December 2013. Italic denotes statistically 
significant improvement from visit 1 to visit 4. Quality assurance officer visually confirmed presence or absence of equipment which was recorded 
via a standardized checklist
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The availability of general laboratory supplies was 
relatively high across the four QA visits except for pH 
paper and RDTs; 43% (n = 34) of facilities had pH paper 
and 23% (n = 18) had RDTs at the last visit as shown in 
Table 2. Lancets, methanol, gloves, lens tissue, lens clean-
ing fluid and Giemsa all significantly increased across 
the QA pilot. At the first visit, 65% (n  =  52) of health 
facilities had the recommended Giemsa for preparation 
of blood smears for malaria microscopy. By the fourth 
visit, 95% (n = 76) of health facilities had Giemsa avail-
able (p < 0.001). In addition, health facilities began using 
Giemsa rather than Field stain for malaria microscopy 
immediately following introduction by the QA officers 
as shown in Fig. 2. In June 2013, 33% (n = 26) of facili-
ties were observed using Giemsa, and by December 2013, 
84% (n = 67) were using Giemsa (p < 0.001) (Fig. 2).
Overall, the observed availability of at least one 
copy each of laboratory reference materials such as the 
national malaria policy, guidelines and job aids signifi-
cantly increased from the first to last visits except for 
the RDT job aid as shown in Fig. 3. Only 31% (n =  25) 
of health facilities had the national malaria policy at the 
first visit compared to 59% (n =  47) by the fourth visit 
(p  <  0.001). Only 25% (n  =  20) of health facilities had 
the national malaria laboratory guidelines in June 2013 
compared to 55% (n = 44) in December 2013 (p < 0.001). 
The percentage of facilities with national malaria 
parasitological diagnosis guidelines and laboratory qual-
ity assurance guidelines both significantly increased 
across the QA pilot (p = 0.05 for both indicators). Across 
the six malaria microscopy job aids, the mean increase 
in availability from the first to last QA visit was 32 per-
centage points (p  <  0.001); the largest increase was for 
the microscopy images job aid (40 percentage points, 
p < 0.001).
Documentation of internal and external QA activi-
ties showed significant increases over the pilot period as 
shown in Fig. 4. At the first visit, only 18% (n = 14) of facil-
ities were using positive-control slides to check the quality 
of buffer and stain compared to 59% (n = 47) facilities by 
the end of the QA pilot (p < 0.001). Initially, 28% (n = 22) 
of facilities conducted an internal cross-check of slides 
compared to 55% (n = 44) at the last visit (p < 0.001), and 
18% (n =  14) of facilities provided slides for an external 
reference cross-check compared to 89% (n =  71) at the 
last visit (p < 0.001). Ten percent (n = 8) of facilities ini-
tially were recording internal QA activities compared to 
61% (n =  49) at the final visit (p < 0.001). Thirteen per-
cent (n = 10) of facilities reported initially participating in 
a malaria-specific external QA programme compared to 
78% (n = 62) by the final visit (p < 0.001). The percentage 
of facilities that reported participating in any other labo-
ratory external QA programme did not increase signifi-
cantly across the QA pilot (p = 0.14).
Table 2 Health facilities with observed laboratory supplies in malaria low-transmission areas in Kenya, June–December 
2013
Italic denotes statistically significant improvement from visit 1 to visit 4
Item Percentage of health facilities with supply availability, N = 80
Visit 1:  
June
Visit 2:  
July
Visit 3:  
November
Visit 4:  
December
Change in percentage  
from visits 1 to 4
p value
Lancets 74 84 84 88 14 0.04
Methanol 55 79 85 89 34 <0.001
Soap 94 96 96 99 5 0.22
Detergent 96 99 100 100 4 0.25
Disinfectant 95 95 99 98 3 0.69
Cotton wool 96 96 96 100 4 0.25
Cotton gauze 91 96 98 96 5 0.34
Pencils 86 93 98 95 9 0.12
Gloves 93 99 100 100 7 0.03
pH paper 40 30 40 43 3 0.88
Lens tissue 59 86 93 91 32 <0.001
Lens cleaning fluid 46 83 91 90 44 <0.001
Slides 94 89 80 94 0 1.00
Immersion oil 99 93 91 100 1 1.00
Giemsa 65 89 86 95 30 <0.001
Field stain 89 76 84 81 (−8) 0.29
Rapid diagnostic tests 33 35 29 23 (−10) 0.22
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Fig. 2 Stain type for malaria microscopy in facilities in low-transmission areas of Kenya, June–December 2013. Italic denotes statistically significant 
improvement from visit 1 to visit 4. Quality assurance officer visually observed type of stain in use which was recorded via a standardized checklist
Fig. 3 Facilities with malaria reference materials in malaria low-transmission areas of Kenya, June–December 2013. RDT rapid diagnostic test. Italic 
denotes statistically significant improvement from visit 1 to visit 4. Quality assurance officer visually confirmed presence or absence of documents 
and job aids which were recorded via a standardized checklist
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The percentage of health-facility laboratories with 
observed SOPs for both microscopy and RDTs also sig-
nificantly increased across the pilot period as shown in 
Fig.  5. Across the seven malaria microscopy SOPs, the 
mean increase in availability from the first to last QA 
visit was 40 percentage points (p  <  0.001); the largest 
increase was for the Giemsa preparation SOP (57 per-
centage points, p  <  0.001). The percentage of health 
facilities documented as having the RDT SOP increased 
from 18% (n  =  14) to 35% (n  =  28) (p  <  0.01). How-
ever, despite significant improvements in SOP avail-
ability over the QA pilot, less than half of facilities had 
the buffer preparation (38%), microscope maintenance 
(46%) and RDT (35%) SOPs by the final visit. Eleven 
percent (n  =  9) of facilities had SOPs that had been 
updated in the previous 12  months at the start of the 
QA pilot compared to 38% (n  =  30) by the final visit 
(p < 0.001).
As shown in Fig. 6, the availability of two safety SOPs 
for infection prevention and post-exposure prophylaxis 
and the observed use of personal protective equipment 
did not increase significantly over the QA pilot. The QA 
officers observed a significant increase in proper waste 
disposal practices (74–93%, p  <  0.01) and labelled con-
tainers (59–76%, p = 0.02) across the QA pilot.
Malaria blood slides were read by health-facility labo-
ratory personnel, QA officers and reference labora-
tory personnel, and the results are shown in Table  3. 
Compared to the reference laboratory, health-facility 
laboratory personnel read slides with a high specificity 
(98% at last visit; range 88–98%) and high negative pre-
dictive value (NPV) (98% at last visit; range over visits 
98–99%). However, health-facility laboratory personnel 
under-performed in sensitivity (53% at last visit; range 
over visits 53–96%) and positive predictive value (PPV) 
(47% at last visit; range over visits 39–53%). The kappa 
(κ) value, which describes the inter-reader agreement 
between health-facility personnel and reference labora-
tory, was 0.48 at the last visit and ranged between 0.48 
and 0.66 over the visits. The only statistically significant 
performance improvement for health-facility personnel 
over time was for specificity; personnel improved the 
specificity at which they read slides compared to the ref-
erence laboratory by 10 percentage points from 88% (95% 
CI 85–90%) to 98% (95% CI 97–99%).
Compared to the reference laboratory, QA officers also 
read slides with a high specificity (99% at last visit; range 
93–99%) and high NPV (99% across all visits). The QA 
officers also under-performed compared to the reference 
laboratory in sensitivity (60% at last visit; range over vis-
its 60–96%) and PPV (56% at last visit; range over visits 
52–80%). The ĸ value was 0.57 at the last visit and ranged 
between 0.57 and 0.84 over all visits. The only statistically 
significant performance improvement for QA officers 
over time was also for specificity; QA officers improved 
the specificity at which they read slides compared to the 
reference laboratory by six percentage points from 93% 
(95% CI 91–95%) to 99% (95% CI 97–99%).
Fig. 4 Facilities with laboratory quality assurance practices in malaria low-transmission areas of Kenya, June–December 2013. QA quality assurance. 
Italic denotes statistically significant improvement from visit 1 to visit 4. Quality assurance officer visually observed presence or absence of practices 
and confirmed documentation which were recorded via a standardized checklist
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Discussion
Overall participation in the QA pilot implementation 
was high. Only one QA officer and three health facilities 
initially selected did not complete the QA pilot. One QA 
officer, who worked in the most remote geographic loca-
tion and was assigned two health facilities, opted out of 
the programme for security and travel-related reasons. 
One hospital decided not to participate after starting the 
Fig. 5 Facilities with malaria diagnostic standard operating procedures in malaria low-transmission areas of Kenya, June–December 2013. RDT rapid 
diagnostic test. Italic denotes statistically significant improvement from visit 1 to visit 4. Quality assurance officer visually confirmed presence or 
absence of documentation which was recorded via a standardized checklist
Fig. 6 Facilities with laboratory safety procedures and practices in malaria low-transmission areas of Kenya, June–December 2013. SOP standard 
operating procedure, PPE personal protective equipment. Italic denotes statistically significant improvement from visit 1 to visit 4. Quality assurance 
officer visually confirmed presence or absence of documentation and observed practices which were recorded via a standardized checklist
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QA pilot programme because the administration believed 
that the programme was punitive despite attending the 
orientation workshop and subsequent briefings and reas-
surances by laboratory and NMCP supervisors.
Similar to the situation in other sub-Saharan African 
countries, the evaluation demonstrated a lack of micros-
copy equipment and trained staff at the health-facility level 
across a wide geographic area in Kenya [17–19]. Despite 
national and WHO guidelines that recommend labora-
tory personnel attend regular malaria diagnostic training 
to ensure proficiency, fewer than one in seven laboratory 
staff had completed any malaria diagnostic training and 
only one in 17 had completed malaria microscopy training 
in the 12 months before the QA pilot commenced [5, 14]. 
Although the majority of facilities had more than one func-
tional microscope, over one-third of microscopes across 
all facilities were not in working condition. The majority 
of facilities were lacking essential microscopy laboratory 
equipment such as tally counters and calculators. Overall, 
almost all health facilities had supplies of general labora-
tory commodities beyond the small seed stocks from the 
QA pilot. Historically in Kenya, health facilities charged a 
small fee for malaria microscopy (i.e., 50 Kenya Shillings 
or approximately $0.60 in 2013) and other laboratory tests, 
which was used, in part, to procure laboratory consuma-
bles. However, in July 2013, public health-facility fees were 
removed by government order. Although the removal of 
health-facility fees seems to have not had a substantial 
negative effect on the supply of laboratory consumables 
available at the facility level in the short term, it is unclear 
if laboratory supply levels will remain adequate and stable 
in the longer term.
The primary goal of the QA programme was to 
improve the accuracy of malaria diagnosis by microscopy 
and malaria RDTs in the supported health facilities. For 
malaria diagnosis by microscopy, the findings demon-
strate no overall performance improvement by health-
facility laboratory personnel during the 7-month QA 
pilot. Based on the observations, routine microscopy in 
low-transmission settings has high specificity (98%) and 
NPV (98%), which should provide confidence among cli-
nicians that negative slides are truly negative. More prob-
lematic are the sensitivity and PPV of routine microscopy 
in low-transmission settings. The overall slide positivity 
of persons presenting with suspected malaria at health 
facilities ranged from 3 to 7%, which is consistent with 
other estimates in low-transmission areas of Kenya [12, 
19, 20]. The sensitivity was high in the second and third 
QA visits, 96 and 89%, respectively, but decreased to 
just 53% during the fourth QA visit in December 2013. 
Thus, in December 2013, only one of every two slides 
read as positive was truly positive, leading to likely 
over-treatment of malaria and under-diagnosis and 
under-treatment of the actual cause of fever and associ-
ated symptoms.
The December 2013 sensitivity might be an outlier 
and explained by a combination of factors outside the 
control of the QA programme. In early 2013, Kenya 
devolved responsibility for health service delivery to 
the county governments as set forth in the 2010 Con-
stitution of Kenya. By the last quarter of 2013, counties 
were validating the employment status of health work-
ers, which resulted in many health workers returning to 
their government-assigned facilities, and counties were 
beginning to hire additional health workers to fill vacan-
cies. Therefore, factors affecting the diagnostic perfor-
mance indicators in December 2013 likely included high 
staff turnover from returning and newly hired laboratory 
personnel who did not benefit from previous QA visits, 
a health worker strike from December 2013 to January 
2014, and temporary staff hired over the holiday season 
as described by Wafula et al. in another external QA pro-
gramme in western Kenya [21].
While the low prevalence of malaria helps to explain 
the low PPVs (range 39–53%) and high NPVs (98–99%) 
observed, the kappa value (range 0.48–0.66) for inter-
reader agreement between health-facility laboratory per-
sonnel and reference laboratory personnel indicates only 
moderate agreement. The performance of QA officers, 
who were the “technical experts” providing on-the-job 
training and mentoring to health-facility laboratory per-
sonnel, was only marginally better than health-facility 
laboratory personnel across all microscopy test perfor-
mance measures. Therefore, the results of the pilot QA 
programme support national and WHO recommenda-
tions of using malaria RDTs in outpatient facilities (i.e., 
dispensaries, health centres and hospital outpatient 
clinics) in low-transmission settings and using malaria 
microscopy for inpatient case management of compli-
cated cases (i.e., severe malaria or suspected treatment 
failures) [9, 22]. Evidence from Senegal demonstrates that 
the use of malaria RDTs is achievable on a national scale 
with associated improvements in case management out-
comes [23].
Over the course of the QA pilot, the performance of 
RDT indicators lagged compared to microscopy indi-
cators, which was unexpected. The causes might have 
included lack of RDT availability, limited time for on-
the-job training or lack of prioritization of RDT training 
by QA officers. The QA officers spent 1  day per month 
at each facility and might have focused more on micros-
copy and general laboratory QA/QC training since they 
were selected because of their technical expertise in 
these areas. Support for the latter is demonstrated by 
the significant overall improvements in microscopy and 
QA/QC practice indicators. Due to a fire at the central 
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medical stores in January 2013 that destroyed over 4 mil-
lion malaria RDTs and other health commodities, only 
one-third of facilities had malaria RDTs in June 2013 and 
less than a quarter had RDTs by December 2013. As a 
result, the majority of facilities did not have RDTs avail-
able for patient care or training during the QA pilot.
The QA pilot had a substantial positive impact on the 
availability of laboratory reference materials and SOPs 
in health-facility laboratories. Over the course of the 
7-month QA pilot, the largest gains were observed in 
the availability of microscopy job aids and SOPs. The QA 
pilot also positively impacted internal and external QA 
practices such as cross-checking slides and recording QA 
activities across health facilities. Health facility participa-
tion in other laboratory external quality assurance pro-
grammes did not change significantly over the course of 
the QA pilot, which suggests that the malaria diagnostics 
QA pilot was responsible for the improvements observed.
To help meet the overall goal of the QA programme 
to strengthen malaria diagnostic accuracy, the QA pilot 
introduced Giemsa in health-facility laboratories that had 
historically used Field stain. Both the NMCP and WHO 
recognize Giemsa as the stain of choice for malaria labo-
ratories [5, 14]. Giemsa is the preferred stain for routine 
malaria microscopy because it can be used to prepare 
both thick and thin blood films, the stain powder is sta-
ble during storage and it has a consistent, reproducible 
staining quality over a range of temperatures [5]. Giemsa 
is relatively more expensive than Field stain, which might 
limit its use by health facilities. To encourage uptake, 
QA officers were given seed stocks of Giemsa to deliver 
during the initial QA visit; the Giemsa seed stock was 
expected to last for several months. Based on the evi-
dence, health facilities had availability and were preferen-
tially using Giemsa for malaria microscopy by the end of 
the QA pilot implementation period.
The QA pilot had a number of limitations. First, health 
facilities were not randomly selected for participation 
in the QA programme thus introducing selection bias. 
Health facilities were purposefully chosen based on 
the distance from the duty location of the QA officer in 
order to decrease travel time and expenses. As a result, 
the convenience sample of selected health facilities is 
likely not representative and the findings might not be 
generalizable to the whole population of health facilities 
in low-transmission regions of Kenya. Second, the QA 
pilot was only 7 months in duration and coincided with 
a tumultuous period in the health system as a result of 
the devolution of government health services in 2013. A 
longer pilot and evaluation period would have allowed 
for more observation points and better estimates of per-
formance outcomes. The last observation point was also 
in a holiday month when health workers were on strike, 
and there were substantial staffing changes happening 
concurrently. Therefore, the observations from Decem-
ber 2013 might have been outliers and not reflected the 
true impact of the QA programme.
Other limitations were related to the scope, ownership 
and timing of the QA pilot. The QA officers were labora-
tory supervisors from primary and secondary hospitals 
with high workloads and many responsibilities in their 
assigned positions. The QA officers devoted 1  day per 
month to each of the supported facilities, which limited 
the time available for one-on-one training and mentor-
ing, particularly in larger facilities with more laboratory 
staff. The facility laboratory managers and administra-
tors were responsible for implementing QA officer rec-
ommendations, but during the last half of 2013, facility 
administrators were faced with many other pressing pri-
orities such as validating staff employment, identifying 
staffing gaps and hiring priorities, eliminating service 
fees and commodity shortages resulting from devolution 
of health services.
Conclusions
The quality of routine malaria microscopy in health 
facilities in Kenya remains below accepted international 
standards. The observations from the QA pilot are con-
sistent with findings from another recent external QA 
programme implemented in a limited number of rural 
health facilities in western Kenya and provide additional 
evidence for a coordinated approach to strengthening 
malaria diagnostics across the larger clinical and labora-
tory systems [21, 24]. Significant gains were observed in 
malaria diagnostic QA/QC practices over the pilot. How-
ever, these advances did not translate into the primary 
programme goal of improving accuracy of malaria diag-
nostic performance perhaps because of the timing and 
limited duration of the QA pilot implementation.
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